Duvall Melody G, Precopio Melissa L, Ambrozak David A, Jaye Assan, McMichael Andrew J, Whittle Hilton C, Roederer Mario, Rowland-Jones Sarah L, Koup Richard A
MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Eur J Immunol. 2008 Feb;38(2):350-63. doi: 10.1002/eji.200737768.
HIV-2 is distinguished clinically and immunologically from HIV-1 infection by delayed disease progression and maintenance of HIV-specific CD4(+) T cell help in most infected subjects. Thus, HIV-2 provides a unique natural human model in which to investigate correlates of immune protection against HIV disease progression. Here, we report a detailed assessment of the HIV-2-specific CD4(+) and CD8(+) T cell response compared to HIV-1, using polychromatic flow cytometry to assess the quality of the HIV-specific T cell response by measuring IFN-gamma, IL-2, TNF-alpha, MIP-1beta, and CD107a mobilization (degranulation) simultaneously following Gag peptide stimulation. We find that HIV-2-specific CD4(+) and CD8(+) T cells are more polyfunctional that those specific for HIV-1 and that polyfunctional HIV-2-specific T cells produce more IFN-gamma and TNF-alpha on a per-cell basis than monofunctional T cells. Polyfunctional HIV-2-specific CD4(+) T cells were generally more differentiated and expressed CD57, while there was no association between function and phenotype in the CD8(+) T cell fraction. Polyfunctional HIV-specific T cell responses are a hallmark of non-progressive HIV-2 infection and may be related to good clinical outcome in this setting.
在临床上和免疫学上,HIV-2与HIV-1感染有所不同,其疾病进展较为缓慢,且在大多数感染个体中能维持HIV特异性CD4(+) T细胞辅助功能。因此,HIV-2提供了一个独特的天然人类模型,可用于研究针对HIV疾病进展的免疫保护相关因素。在此,我们报告了与HIV-1相比,对HIV-2特异性CD4(+)和CD8(+) T细胞反应的详细评估,使用多色流式细胞术通过在Gag肽刺激后同时测量IFN-γ、IL-2、TNF-α、MIP-1β和CD107a动员(脱颗粒)来评估HIV特异性T细胞反应的质量。我们发现,HIV-2特异性CD4(+)和CD8(+) T细胞比HIV-1特异性T细胞具有更多的多功能性,并且多功能HIV-2特异性T细胞在每个细胞基础上产生的IFN-γ和TNF-α比单功能T细胞更多。多功能HIV-2特异性CD4(+) T细胞通常分化程度更高且表达CD57,而在CD8(+) T细胞组分中,功能与表型之间没有关联。多功能HIV特异性T细胞反应是非进展性HIV-2感染的一个标志,并且在这种情况下可能与良好的临床结果相关。